Company Email Format Management

CROSSJECT

Pharmaceutical Manufacturing Kergomard, Fr 97 employees

Employees: 97

crossject.com LinkedIn Crunchbase

CROSSJECT Overview

Headquarters: Kergomard, Fr
Phone Number: Available in AeroLeads
Website: crossject.com
Industry: Pharmaceutical Manufacturing
Employees: 97
Founded: 2001
Funding: 6.6M
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Injection sans aiguile and Traitements d'urgence

About CROSSJECT

Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal insufficiencies, opioid overdose and asthma attacks.

CROSSJECT Contact Details

People in AeroLeads: 3

CROSSJECT Org Chart

Sample employees and titles

Name	Title	Location	Contact
Xaviere Castano			View
Daniel Teper	Founder and CEO @ Naya Therapeutics - Insead Mba, Pharmd	Miami, Florida, United States	View
Charley Michaux	Director of Purchasing		View